Shattuck Labs, Inc. - Common Stock — Cash Flow (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -33.66 M-57.12 M-94.5 M-81.23 M-60.52 M-39.88 M -41.03 M Cash from investing activities -146.32 M-10.44 M49.44 M110.86 M-8.51 M-7.89 M -144.59 M Cash from financing activities 330.87 M1.93 M171 K48.62 M787 K44.57 M 198.44 M Free cash flow -33.66 M-57.12 M-94.5 M-81.23 M-60.52 M-39.88 M -41.03 M

News

Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?

Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08

Shattuck Labs: "Hold" On Phase 1 SL-325 Data And Next Stage Of Development (NASDAQ:STTK)

Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update Transcript

Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation (NASDAQ:STTK)

Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK)

Shattuck Labs stock maintained at Buy by TD Cowen on drug data

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright